[go: up one dir, main page]

MX2016009060A - Metodos y sistemas para determinar el riesgo de falla cardiaca. - Google Patents

Metodos y sistemas para determinar el riesgo de falla cardiaca.

Info

Publication number
MX2016009060A
MX2016009060A MX2016009060A MX2016009060A MX2016009060A MX 2016009060 A MX2016009060 A MX 2016009060A MX 2016009060 A MX2016009060 A MX 2016009060A MX 2016009060 A MX2016009060 A MX 2016009060A MX 2016009060 A MX2016009060 A MX 2016009060A
Authority
MX
Mexico
Prior art keywords
heart failure
methods
systems
determining risk
subject
Prior art date
Application number
MX2016009060A
Other languages
English (en)
Inventor
W Gerwien Robert
V Snider James
Original Assignee
Critical Care Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Critical Care Diagnostics Inc filed Critical Critical Care Diagnostics Inc
Publication of MX2016009060A publication Critical patent/MX2016009060A/es

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Inorganic Chemistry (AREA)

Abstract

Se proporcionan métodos, algoritmos, nomogramas y sistemas de computadora/software que se pueden utilizar para determinar con precisión el riesgo de desarrollar falla cardiaca dentro de un período de tiempo específico en un sujeto no diagnosticado o que presenta falla cardiaca. También se proporcionan métodos, algoritmos, nomogramas, sistemas de computadora/software para seleccionar un tratamiento para un sujeto y determinar la eficacia de un tratamiento para reducir el riesgo de falla cardiaca en un sujeto.
MX2016009060A 2014-01-10 2015-01-09 Metodos y sistemas para determinar el riesgo de falla cardiaca. MX2016009060A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461925877P 2014-01-10 2014-01-10
PCT/US2015/010788 WO2015106081A1 (en) 2014-01-10 2015-01-09 Methods and systems for determining risk of heart failure

Publications (1)

Publication Number Publication Date
MX2016009060A true MX2016009060A (es) 2016-09-09

Family

ID=53521621

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009060A MX2016009060A (es) 2014-01-10 2015-01-09 Metodos y sistemas para determinar el riesgo de falla cardiaca.

Country Status (8)

Country Link
US (2) US20150199491A1 (es)
EP (1) EP3092488A4 (es)
JP (2) JP6655016B2 (es)
CN (2) CN113744876A (es)
AU (1) AU2015204675A1 (es)
CA (1) CA2935958A1 (es)
MX (1) MX2016009060A (es)
WO (1) WO2015106081A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002218026A1 (en) 2000-11-09 2002-05-21 The Brigham And Women's Hospital, Inc. Cardiovascular disease diagnostic and therapeutic targets
AU2003234407B2 (en) 2002-05-09 2008-12-18 The Brigham And Women's Hospital, Inc. 1L1RL-1 as a cardiovascular disease marker and therapeutic target
US7998683B2 (en) 2006-04-24 2011-08-16 Critical Care Diagnostics, Inc. Predicting mortality and detecting severe disease
EP3059594A1 (en) 2006-05-01 2016-08-24 Critical Care Diagnostics, Inc. Prognosis of cardiovascular disease
EP3378955A1 (en) 2008-04-18 2018-09-26 Critical Care Diagnostics, Inc. Predicting risk of major adverse cardiac events
RU2684724C2 (ru) 2010-04-09 2019-04-11 Критикал Кэа Дайэгностикс, Инк. Антитела против растворимого st-2 человека и способы анализа
JP6215713B2 (ja) 2011-03-17 2017-10-18 クリティカル ケア ダイアグノスティクス インコーポレイテッド 有害臨床転帰のリスクを予測する方法
DK2734222T3 (en) 2011-07-18 2017-01-30 Critical Care Diagnostics Inc PROCEDURES FOR TREATING CARDIOVASCULAR DISEASES AND PREDICTING THE EFFECTIVENESS OF MOTION THERAPY
DK2885641T3 (da) 2012-08-16 2018-01-29 Critical Care Diagnostics Inc Fremgangsmådeer til forudsigelse af risiko for udvikling af hypertension
HK1212057A1 (en) 2012-08-21 2016-06-03 重症监护诊断股份有限公司 Multimarker risk stratification
EP4445834A3 (en) * 2017-04-29 2024-12-25 Cardiac Pacemakers, Inc. Heart failure event rate assessment
US10952681B2 (en) * 2017-09-05 2021-03-23 Medtronic, Inc. Differentiation of heart failure risk scores for heart failure monitoring
JP7024576B2 (ja) * 2018-04-20 2022-02-24 オムロンヘルスケア株式会社 電子血圧計および心不全検出器
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
EP4162278A4 (en) * 2020-06-03 2024-08-14 ESN Cleer BIOMARKER IDENTIFICATION FOR IMPENDING AND/OR IMPENDING HEART FAILURE
GB202008994D0 (en) 2020-06-12 2020-07-29 Univ Edinburgh Assay method

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0590200A1 (en) * 1992-10-02 1994-04-06 E.R. SQUIBB & SONS, INC. Device and method for the visualisation of cardiovascular risk factors
US6409664B1 (en) 1997-07-01 2002-06-25 Michael W. Kattan Nomograms to aid in the treatment of prostatic cancer
US5993388A (en) 1997-07-01 1999-11-30 Kattan; Michael W. Nomograms to aid in the treatment of prostatic cancer
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
ATE363917T1 (de) * 2001-07-19 2007-06-15 Pharmacia Corp Kombination von einem aldosterone rezeptor antagonisten und einem hmg coa reduktase hemmer
US6881193B2 (en) * 2001-09-27 2005-04-19 Charlotte-Mecklenburg Hospital Non-invasive device and method for the diagnosis of pulmonary vascular occlusions
US7998683B2 (en) 2006-04-24 2011-08-16 Critical Care Diagnostics, Inc. Predicting mortality and detecting severe disease
ATE517341T1 (de) 2006-04-27 2011-08-15 Critical Care Diagnostics Inc Interleukin-33 (il-33) zur diagnose und vorhersage von herz-gefäss-erkrankungen
EP3059594A1 (en) 2006-05-01 2016-08-24 Critical Care Diagnostics, Inc. Prognosis of cardiovascular disease
EP2019965B1 (en) 2006-05-02 2015-04-15 Critical Care Diagnostics, Inc. Differential diagnosis between pulmonary and cardiovascular disease
US20080057590A1 (en) * 2006-06-07 2008-03-06 Mickey Urdea Markers associated with arteriovascular events and methods of use thereof
ES2730879T3 (es) * 2008-01-04 2019-11-13 Univ Oxford Innovation Ltd Cuerpos de cetona y ésteres de cuerpos de cetona como agentes reductores de lípidos de la sangre
EP3378955A1 (en) * 2008-04-18 2018-09-26 Critical Care Diagnostics, Inc. Predicting risk of major adverse cardiac events
JP5584695B2 (ja) * 2008-11-11 2014-09-03 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング Ａｄｍ及びｂｎｐのレベルを決定することによる心疾患に罹患した患者の予後診断及びリスク評価
RU2684724C2 (ru) 2010-04-09 2019-04-11 Критикал Кэа Дайэгностикс, Инк. Антитела против растворимого st-2 человека и способы анализа
EP2609427B1 (en) * 2010-08-26 2015-01-21 Roche Diagnostics GmbH Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
US20130280716A1 (en) * 2010-11-10 2013-10-24 The Cleveland Clinic Foundation Ratio of apoa2 to HDLc or Equivalents thereof, Risk Markers for Cardiovascular Disease
HK1212057A1 (en) * 2012-08-21 2016-06-03 重症监护诊断股份有限公司 Multimarker risk stratification

Also Published As

Publication number Publication date
JP6655016B2 (ja) 2020-02-26
WO2015106081A1 (en) 2015-07-16
US20180018442A1 (en) 2018-01-18
JP2017512507A (ja) 2017-05-25
CA2935958A1 (en) 2015-07-16
US20150199491A1 (en) 2015-07-16
JP6995898B2 (ja) 2022-02-04
CN113744876A (zh) 2021-12-03
JP2020089746A (ja) 2020-06-11
AU2015204675A1 (en) 2016-07-28
EP3092488A1 (en) 2016-11-16
CN106461636A (zh) 2017-02-22
EP3092488A4 (en) 2017-07-12

Similar Documents

Publication Publication Date Title
MX2016009060A (es) Metodos y sistemas para determinar el riesgo de falla cardiaca.
PH12017502153A1 (en) Diagnostic methods for t cell therapy
EP3177201C0 (en) SYSTEMS AND METHODS FOR ASSESSING NEURAL ACTIVITY IN THE EYE
GB2549406A (en) Methods for determining health risks
SG10201807147TA (en) Verification methods and verification devices
GB2550524A (en) Selective reminders to complete interrupted tasks
EP3120460A4 (en) Chips including classical and quantum computing processors
ZA201902320B (en) 17alpha,21-diesters of cortexolone for use in the treatment of tumors
GB2559275B (en) Methods and systems for performing actions based on biometric data
EP3186397C0 (en) USE OF BIOMARKERS OF CIRCULATING CELLS IN THE BLOOD FOR THE DETECTION AND DIAGNOSIS OF DISEASES, AND THEIR ISOLATION PROCESSES
EP3344127A4 (en) Physiological monitoring devices and methods that identify subject activity type
EP3153092A4 (en) Pupil detection system, gaze detection system, pupil detection method, and pupil detection program
EP3183701A4 (en) Client, computing platform, and methods for conducting secure transactions
BR112016025511A2 (pt) técnicas para execução serializada em sistema de processamento simd
PH12017500052A1 (en) Myo-inositol and probiotics and uses
TWD181120S (zh) 運算及控制單元之部分
SG11201702806UA (en) Write request processing method, processor, and computer
EP3142553A4 (en) Systems and methods for measurement of oxygen levels in blood by placement of a single sensor on the skin
EP3347844A4 (en) METHOD AND SYSTEM FOR DIAGNOSIS OF DISEASES AND FOR THE PREPARATION OF TREATMENT RECOMMENDATIONS
SG11201703285WA (en) Systems and computer implemented methods for monitoring an activity at one or more facilities
GB201502289D0 (en) Methods and systems for analyzing financial dataset
WO2016004375A3 (en) Methods and materials for treating pain and depression
AU358921S (en) Blood processing device
PH12017500084A1 (en) Vitamin b2 and its use
MX377034B (es) Un eje de entrada entre un aparato y un aparato separado.